首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2807篇
  免费   325篇
  3132篇
  2023年   16篇
  2022年   44篇
  2021年   64篇
  2020年   54篇
  2019年   65篇
  2018年   73篇
  2017年   84篇
  2016年   104篇
  2015年   128篇
  2014年   154篇
  2013年   191篇
  2012年   215篇
  2011年   219篇
  2010年   98篇
  2009年   116篇
  2008年   130篇
  2007年   151篇
  2006年   133篇
  2005年   118篇
  2004年   99篇
  2003年   100篇
  2002年   97篇
  2001年   77篇
  2000年   71篇
  1999年   66篇
  1998年   38篇
  1997年   36篇
  1996年   26篇
  1995年   24篇
  1994年   28篇
  1993年   17篇
  1992年   22篇
  1991年   24篇
  1990年   19篇
  1989年   28篇
  1988年   15篇
  1987年   15篇
  1986年   21篇
  1985年   13篇
  1984年   12篇
  1983年   10篇
  1982年   10篇
  1978年   9篇
  1977年   14篇
  1975年   7篇
  1974年   5篇
  1972年   11篇
  1969年   7篇
  1967年   7篇
  1966年   11篇
排序方式: 共有3132条查询结果,搜索用时 15 毫秒
941.
Pneumonia is responsible for important economical losses in the sheep industry in Spain and many other sheep-rearing countries, being the main cause of lamb death, and of losses due to condemnations in abattoirs and of drug costs. This respiratory syndrome is a complex disease involving the relationship between host and environment. The present study analyses the influence of environmental factors on the development of pneumonia in lambs. Statistically significant correlations were found between pneumonia as a cause of lamb death and climatic factors such as rainfall, humidity and intensity and direction of wind. The type of farm building was also an important factor to take into account in order to improve the prevention of pneumonia in lambs. Moreover, the age of the lambs was seen to be a significant item in the study of pneumonia. Respiratory pathology increased from 23 days of age. This fact permits the implementation of measures from birth to 23 days with a view to reducing pneumonia and its negative influence on lamb production. The paper discusses the practical implications of these findings for sheep production.  相似文献   
942.
Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, we hypothesized that a peptide binder to the CK2 phosphoacceptor site could exhibit anticancer properties in vitro, in tumor animal models, and in cancer patients. By screening a random cyclic peptide phage display library, we identified the CIGB-300 (formerly P15-Tat), a cyclic peptide which abrogates the CK2 phosphorylation by blocking recombinant substrates in vitro. Interestingly, synthetic CIGB-300 led to a dose-dependent antiproliferative effect in a variety of tumor cell lines and induced apoptosis as evidenced by rapid caspase activation. Importantly, CIGB-300 elicited significant antitumor effect both by local and systemic administration in murine syngenic tumors and human tumors xenografted in nude mice. Finally, we performed a First-in-Man trial with CIGB 300 in patients with cervical malignancies. The peptide was found to be safe and well tolerated in the dose range studied. Likewise, signs of clinical benefit were clearly identified after the CIGB-300 treatment as evidenced by significant decrease of the tumor lesion area and histological examination. Our results provide an early proof-of-principle of clinical benefit by using an anti-CK2 approach in cancer. Furthermore, this is the first clinical trial where an investigational drug has been used to target the CK2 phosphorylation domain.  相似文献   
943.
Cheese whey, also known as sweet whey, is a by-product of cheese-making that contains many valuable constituents. Among them, whey proteins stand out for their high nutritional value in terms of biological value and composition in essential amino acids. In recent years, the increasing demand for caprine and ovine cheeses has produced important amounts of whey from these species, boosting research on the biological activities of its constituent proteins. Different bioactivities have been associated to these proteins, among them antihypertensive, antimicrobial, opioid, antioxidant and immunomodulant activity being the most studied. Although biological activities are present in the intact proteins, in many cases whey proteins act as precursors of bioactive peptides that are released from the hydrolysis of these proteins with different enzymes. This review presents an overview of the different biological activities described for caprine and ovine cheese whey proteins as well as for other whey components such as lactose, oligosaccharides or minerals.  相似文献   
944.

Summary

A poly (A)-binding protein from Leishmania infantum (LiPABP) has been recently cloned and characterized in our laboratory. Although this protein shows a very high homology with PABPs from other eukaryotic organisms including mammals and other parasites, exist divergences along the sequence that convert them in potential diagnostic markers and/or therapeutics targets. Aptamers are oligonucleotide ligands that are selected in vitro by their affinity and specificity for the target as a consequence of the particular tertiary structure that they are able to acquire depending on their sequence. Development of high-affinity molecules with the ability to recognize specifically Leishmania proteins is essential for the progress of this kind of study.

Results

We have selected a ssDNA aptamer population against a recombinant 6xHIS–LiPABP protein (rLiPABP) that is able to recognize the target with a low Kd. Cloning, sequencing and in silico analysis of the aptamers obtained from the population yielded three aptamers (ApPABP#3, ApPABP#7 and ApPABP#11) that significantly bound to PABP with higher affinity than the naïve population. These aptamers were analyzed by ELONA and slot blot to establish affinity and specificity for rLiPABP. Results demonstrated that the three aptamers have high affinity and specificity for the target and that they are able to detect an endogenous LiPABP (eLiPABP) protein amount corresponding to 2500 L. infantum promastigotes in a significant manner. The functional analysis of the aptamers also revealed that ApPABP#11 disrupts the binding of both Myc-LiPABP and eLiPABP to poly (A) in vitro. On the other hand, these aptamers are able to bind and purify LiPABP from complex mixes.

Conclusion

Results presented here demonstrate that aptamers represent new reagents for characterization of LiPABP and that they can affect LiPABP activity. At this respect, the use of these aptamers as therapeutic tool affecting the physiological role of PABP has to be analyzed.  相似文献   
945.
BackgroundChronic chagasic cardiomyopathy (CCC), the main clinical sign of Chagas disease, is associated with systemic CD8+ T-cell abnormalities and CD8-enriched myocarditis occurring in an inflammatory milieu. Pentoxifylline (PTX), a phosphodiesterase inhibitor, has immunoregulatory and cardioprotective properties. Here, we tested PTX effects on CD8+ T-cell abnormalities and cardiac alterations using a model of experimental Chagas’ heart disease.Conclusions/SignificancePTX therapy ameliorates critical aspects of CCC and repositioned CD8+ T-cell response towards homeostasis, reinforcing that immunological abnormalities are crucially linked, as cause or effect, to CCC. Therefore, PTX emerges as a candidate to treat the non-beneficial immune deregulation associated with chronic Chagas'' heart disease and to improve prognosis.  相似文献   
946.
947.
948.
949.
Human epidermal growth factor receptor 2 (ErbB2) is a transmembrane oncoprotein that is over expressed in breast cancer. A successful therapeutic treatment is a monoclonal antibody called trastuzumab which interacts with the ErbB2 extracellular domain (ErbB2-ECD). A better understanding of the detailed structure of the receptor-antibody interaction is indeed of prime interest for the design of more effective anticancer therapies. In order to discuss the flexibility of the complex ErbB2-ECD/trastuzumab, we present, in this study, a multi-nanosecond molecular dynamics simulation (MD) together with an analysis of fluctuations, through a principal component analysis (PCA) of this system. Previous to this step and in order to validate the simulations, we have performed a detailed analysis of the variable antibody domain interactions with the extracellular domain IV of ErbB2. This structure has been statically elucidated by x-ray studies. Indeed, the simulation results are in excellent agreement with the available experimental information during the full trajectory. The PCA shows eigenvector fluctuations resulting in a hinge motion in which domain II and CH domains approach each other. This move is likely stabilized by the formation of H-bonds and salt bridge interactions between residues of the dimerization arm in the domain II and trastuzumab residues located in the CH domain. Finally, we discuss the flexibility of the MD/PCA model in relation with the static x-ray structure. A movement of the antibody toward the dimerization domain of the ErbB2 receptor is reported for the first time. This finding could have important consequences on the biological action of the monoclonal antibody.
Figure
Trastuzumab Fab approaching the ErbB2 dimerization arm  相似文献   
950.

Background

Salivary gland-type tumors originating in the nasopharynx are rare, and only a few articles about mucoepidermoid carcinomas (MEC) in this location have been reported. We describe one case of nasopharyngeal MEC and, based on a review of the literature, discuss different therapeutic approaches that can be taken regarding the result of histological findings, radiological tests and extent of disease.

Case presentation

A 47-year-old woman diagnosed with mucoepidermoid carcinoma of nasopharynx, T1 N3 M0 (stage IV-B) was treated in 2007 with a combination of radiotherapy and chemotherapy to a maximum dose of 70 Gy and concomitant Cisplatin during the radiation. One year later, with the head and neck disease under control, mediastinal nodes relapse appeared which were treated with exclusive radiotherapy to a maximum dose of 65 Gy. One year after the first relapse, a second relapse was detected in the right lung, next to the previously treated mediastinal regions, and the patient initiated a treatment with exclusive chemotherapy based on TPF scheme.

Conclusion

For limited or resectable MEC, combined surgery with radiotherapy, or radiochemotherapy, should be considered the main treatment policy. On the other hand, in poorly differentiated, unresectable tumors or nasopharyngeal MEC, radiochemotherapy could be currently the main treatment approach.  相似文献   
[首页] « 上一页 [90] [91] [92] [93] [94] 95 [96] [97] [98] [99] [100] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号